M&A Watch - Mergers and acquisitions in the healthcare industry

Key Takeaways in the Q2 2013 Report

Merger and acquisition activity fell to 229 deals from 249 in the first quarter, but higher values on individual deals drove total dollar volume to near record levels at $49.9 billion.
Several major mergers drove the higher deal dollar value, including Thermo Fisher Scientific’s takeover of Life Technologies Corp. for $13.6 billion and Valeant Pharmaceuticals’ purchase of Bausch & Lomb for $8.7 billion.
Hospital mergers seized center stage with two of the top five deals during the quarter led by Tenet Healthcare Corp.’s takeover of Vanguard Health Systems for $4.3 billion.
Providers led the pack in making deals in the second quarter, with hospitals and other provider groups announcing 106 transactions, nearly double its previous quarter’s total.

Buy all the reports

2013 Q2 Report | Data

2013 Q1 Report | Data

2012 Q4 Report | Data

2012 Q3 Report | Data

2012 Q2 Report | Data

2012 Q1 Report | Data

Top Five Deals ($ in millions)

Target	Location	Seller (if applicable)	Bidder	Industry	Sub-sector	Purchase price	Deal announced
Life Technologies	Carlsbad, Calif.	-	Thermo Fisher Scientific	Medical devices	Diagnostics	$13,600	4/15/2013
Bausch & Lomb	Rochester, N.Y.	--	Valeant Pharmaceuticals	Pharmaceuticals	Drugs and biologics	$8,700	5/27/2013
Warner Chilcott	Rockaway, N.J.	-	Actavis	Pharmaceuticals	Drugs and biologics	$8,500	5/20/2013
Vanguard Health Systems	Nashville	-	Tenet Healthcare Corp.	Providers	Hospitals, acute-care	$4,300	6/24/2013
Revera	Ontario, Canada	--	Health Care REIT	Providers	Senior housing	$1,350	5/8/2013

Buy all the 2nd Qtr 2013 M&A data »

Target	Location	Seller (if applicable)	Bidder	Industry	Sub-sector	Purchase price	Deal announced
Vanguard Health Systems	Nashville	-	Tenet Healthcare Corp.	Providers	Hospitals, acute care	$4,300	6/24/2013
PRA International	Raleigh, N.C.	Genstar Capital	KKR	Pharmaceuticals	Contract research organization	$1,300	6/24/2013
Pearl Therapeutics	Redwood City, Calif.	-	AstraZeneca	Pharmaceuticals	Drugs and biologics	$1,150	6/10/2013
Aragon Pharma	San Diego	-	Johnson & Johnson	Pharmaceuticals	Drugs and biologics	$650	6/17/2013
OrthoRecon business	Arlington, Texas	Wright Medical Group	MicroPort Medical B.V.	Medical devices	Medical implants	$290	6/19/2013

Buy all the June 2013 M&A data »

Target	Location	Seller (if applicable)	Bidder	Industry	Sub-sector	Purchase price	Deal announced
Bausch + Lomb	Rochester, N.Y.	-	Valeant Pharmaceuticals	Pharmaceuticals	Drugs and biologics	$8,700	5/27/2013
Warner Chilcott	Rockaway, N.J.	-	Actavis	Pharmaceuticals	Drugs and biologics	$8,500	5/20/2013
Revera	Ontario, Canada	-	Health Care REIT	Providers	Senior housing	$1,350	5/8/2013
Omthera Pharmaceuticals	Princeton, N.J.	-	AstraZeneca	Pharmaceuticals	Drugs and biologics	$443	5/28/2013
AOP Orphan Pharmaceuticals	Vienna, Austria	-	Elan Pharmaceuticals	Pharmaceuticals	Drugs and biologics	$340	5/20/2013

Buy all the May 2013 M&A data »

Target	Location	Seller (if applicable)	Bidder	Industry	Sub-sector	Purchase price	Deal announced
Life Technologies	Carlsbad, Calif.	-	Thermo Fisher Scientific	Medical devices	Diagnostics	$13,600	4/15/2013
Conceptus	Mountain View, Calif.	-	Bayer HealthCare	Pharmaceuticals	Drugs and biologics	$1,100	4/29/2013
Managed Health Care Associates	Florham Park, N.J.	-	Roper Industries	Medical technology	Imaging	$1,000	4/17/2013
St. Luke's Episcopal Health System	Houston	-	Catholic Health Initiatives	Providers	Hospitals, acute care	$1,000	4/19/2013
Actient Holdings	Lake Forest, Ill.	GTCR (private equity firm)	Auxilium Pharmaceuticals	Pharmaceuticals	Drugs and biologics	$585	4/29/2013

Buy all the April 2013 M&A data »

Sample graphics from the 2013 Q1 Report

About the Healthcare M&A Watch Report

This report series covers trends and analyzes recent activity in the U.S. healthcare mergers and acquisitions market. Activity among the provider, payer, vendor and pharmaceutical/biotechnology sectors of the healthcare industry is comprehensively covered.

This report will help you:

Understand the M&A landscape and implications to consider
See trends and the impact of deal activity among different sectors in healthcare
Identify strategies for your organization's next deal
Identify target markets where the most deals are happening

Latest Healthcare M&A News

Medtronic buys telehealth provider Cardiocom Joseph Conn | 8/12/13 - 3:00 pm FTC, Phoebe Putney in settlement talks over disputed acquisition Joe Carlson | 8/12/13 - 3:15 pm Medtronic enters disease management Wall Street Journal | 8/12/13 - 8:00 am Regional News/Northeast Modern Healthcare | 8/10/13 - 12:01 am SSI buys claims-processing service provider Claimsnet.com Joseph Conn | 8/8/13 - 2:30 pm

More M&A News

How to Make the Strategic Partnering Decision

This white paper offers eight lessons that can help healthcare boards and executive teams make the best-possible strategic partnership decision.

Get the Kaufman Hall white paper

Frequently Asked Questions

Q: What is Healthcare M&A Watch?
A: Healthcare M&A Watch is a digital report produced on a quarterly basis that covers trending and analysis of U.S. mergers and acquisitions among providers, payers, vendors and pharma/life sciences sectors of the healthcare industry. You can purchase the quarterly report individually for $199.

Q: I have a paid ModernHealthcare.com subscription. Can I get the Healthcare M&A Watch for free?
A: Yes, if you are a Premium Web subscriber. Premium Web subscribers have access to all the By The Numbers PDFs and research from Modern Healthcare Insights that are uploaded to our Healthcare Business Data Center.